share_log
Reuters ·  Mar 21 09:53
CSPC Pharmaceutical - Sys6040 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in China From Nmpa
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 341

Recommended

Write a comment